单参数MRI与多参数MRI检测前列腺癌的非劣效性:基于先进「缩放」扩散加权成像的ADC比值诊断准确性
这项单中心研究前瞻性纳入52例男性患者,比较表观扩散系数(ADC)比值作为单参数MRI方案与3.0 T多参数MRI检测前列腺癌的诊断准确性。多参数MRI检出95%的临床显著前列腺癌,单参数ADC比值检出91%至93%,非劣效性检验证实单参数MRI非劣效,ADC比值预测诊断准确性为73.7%至87.8%,多参数MRI为72.2%至84.7%。
要点
- 单参数ADC比值在检出临床显著前列腺癌方面非劣效于3.0 T多参数MRI。
- ADC比值定义为病灶最低信号强度除以原发带正常组织信号强度。
- ADC比值与前列腺癌侵袭性呈令人满意的相关性。
核心结论
- 基于先进扩散加权成像的归一化ADC比值在预选患者队列中检测临床显著前列腺癌非劣效于3.0 T多参数MRI,是一种快速准确的评估工具,可能有助于简化未来前列腺癌筛查方法的开发。
研究设计与样本
- 单中心研究,前瞻性数据收集、回顾性盲法多读者图像分析,根据功效分析纳入52例男性患者,招募时间为2020年1月至12月;基于多参数MRI findings,患者接受MR引导下穿刺活检或前列腺切除术以进行组织病理学对照;三名读者在不知组织病理学结果和多参数MRI图像的情况下独立评估ADC图。
诊断标准与关键数值
- 共81个经组织病理学证实的独特前列腺癌病灶(Gleason评分≥3+3)在52例患者中可明确对应,其中57个为临床显著前列腺癌病灶(Gleason评分≥3+4);多参数MRI检出95%的临床显著前列腺癌,单参数ADC比值检出91%至93%的临床显著前列腺癌;非劣效性经双单侧检验证实(所有比较P<0.05);ADC比值预测诊断准确性为73.7%至87.8%,多参数MRI为72.2%至84.7%;连续ADC比值的Hosmer-Lemeshow检验P=0.55-0.87,Pearson χ2检验P=0.35-0.69(χ2=0.16-0.87)。
临床应用与阅片要点
- 原文结论指出归一化ADC比值基于先进扩散加权成像在预选患者队列中检测临床显著前列腺癌非劣效于3.0 T多参数MRI,并证明是一种快速准确的评估工具,可能有助于简化未来前列腺癌筛查方法的开发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to compare the diagnostic accuracy of apparent diffusion coefficient (ADC) ratios as a monoparametric magnetic resonance imaging (MRI) protocol for the detection of prostate cancer (PCa) with the established multiparametric (mp) MRI at 3.0 T.
MATERIALS AND METHODS: According to power analysis, 52 male patients were included in this monocenter study with prospective data collection and retrospective, blinded multireader image analysis. The study was approved by the local ethics committee. Patients were recruited from January to December 2020. Based on mpMRI findings, patients underwent in-bore MR biopsy or prostatectomy for histopathologic correlation of suspicious lesions. Three readers, blinded to the histopathologic results and images of mpMRI, independently evaluated ADC maps for the detection of PCa. The ADC ratio was defined as the lowest signal intensity (SI) of lesions divided by the SI of normal tissue in the zone of origin. Predictive accuracy of multiparametric and monoparametric MRI were compared using logistic regression analysis. Moreover, both protocols were compared applying goodness-of-fit analysis with the Hosmer-Lemeshow test for continuous ADC ratios and Pearson χ2 test for binary decision calls, correlation analysis with Spearman ρ and intraclass correlation coefficients, as well as noninferiority assessment with a TOST ("two one-sided test").
RESULTS: Eighty-one histopathologically proven, unique PCa lesions (Gleason score [GS] ≥ 3 + 3) in 52 patients could be unequivocally correlated, with 57 clinically significant (cs) PCa lesions (GS ≥ 3 + 4). Multiparametric MRI detected 95%, and monoparametric ADC detected ratios 91% to 93% of csPCa. Noninferiority of monoparametric MRI was confirmed by TOST (P < 0.05 for all comparisons). Logistic regression analysis revealed comparable predictive diagnostic accuracy of ADC ratios (73.7%-87.8%) versus mpMRI (72.2%-84.7%). Spearman rank correlation coefficient for PCa aggressiveness revealed satisfactory correlation of ADC ratios (P < 0.013 for all correlations). The Hosmer-Lemeshow test for the logistic regression analysis for continuous ADC ratios indicated adequate predictive accuracy (P = 0.55-0.87), and the Pearson χ2 test showed satisfactory goodness of fit (P = 0.35-0.69, χ2 = 0.16-0.87).
CONCLUSIONS: Normalized ADC ratios based on advanced DWI are noninferior to mpMRI at 3.0 T for the detection of csPCa in a preselected patient cohort and proved a fast and accurate assessment tool, thus showing a potential prospect of easing the development of future screening methods for PCa.
引用
- Raczeck P, Frenzel F, Woerner T, et al. Noninferiority of Monoparametric MRI Versus Multiparametric MRI for the Detection of Prostate Cancer: Diagnostic Accuracy of ADC Ratios Based on Advanced "Zoomed" Diffusion-Weighted Imaging. Invest Radiol. 2022. PMID: 34743133. doi:10.1097/RLI.0000000000000830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。